These 1,749 significant junctions include 61 of 79 splice sites recently reported as specific to CLL cases with SF3B1 mutations [11] supporting the specificity of our approach while demonstrating an increased sensitivity that has allowed us to identify many more cryptic 3’SSs than previously reported. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.